Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Genprex, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 50 | 1 | 42 | −7 |
| Shares | 4.78M | 13.0K | 4.40M | −368.8K (−7.7%) |
| Value | $10.8M | $29.0K | $6.11M | −$4.66M (−43.3%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Genprex, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 40,181 | $56.0K | 0.00% |
| Pekin Hardy Strauss, Inc. | 12,578 | $17.0K | 0.00% |
Sold out (9)
Institutions that held Genprex, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Gsa Capital Partners LLP | 123,618 | $279.0K |
| Citadel Advisors LLC | 35,958 | $81.0K |
| Cubist Systematic Strategies, LLC | 19,950 | $45.0K |
| Jane Street Group, LLC | 12,200 | $28.0K |
| Two Sigma Advisers, LP | 11,000 | $25.0K |
| Eqis Capital Management, Inc. | 10,287 | $23.0K |
| FMR LLC | 2,168 | $5.00K |
| Citigroup Inc | 1,800 | $4.00K |
| Glassman Wealth Services | 1 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Genprex, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 13,001 | $29.0K |